AGA Family of Websites:
AGA Journals
AGA Journals
AGA University
AGA University
AGA University
AGA Research Foundation
AGA University
AGA Community
AGA University
AGA Job Board
November 20, 2019

Dr. Helene Langevin to provide keynote address at the 2020 Crohn’s & Colitis Congress

The director of the National Center for Complementary and Integrative Health will speak on cross-system integration.
Share on facebook
Share on twitter
Share on linkedin
Share on email

After Helene Langevin, MD, was sworn in as the new director of the National Center for Complementary and Integrative Health (NCCIH) in November 2018, she published a special message for the integrative health care community, outlining her strategic partnerships and priorities for her first official year leading the National Institutes of Health organization.

“Our current approach to patient care, in general, is fundamentally limited,” she said. “It often emphasizes the treatment of disease alone, while it many times neglects the promotion, support and restoration of health. Integrative health care can help correct this limitation by giving more consideration to the patient’s long-term recovery and overall health when treating an acute illness or injury.”

Dr. Langevin’s address at the Crohn’s & Colitis Congress®, will speak to the progress she has made at NCCIH and the concept of cross-system integration and its applications to gastrointestinal physiology and pathophysiology, with special reference to inflammatory bowel disease (IBD) and immune-related conditions.

The Crohn’s & Colitis Congress, a partnership of the Crohn’s & Colitis Foundation and the American Gastroenterological Association, is the premier conference on IBD. It will take place Jan. 23-25, 2020, at the Austin Convention Center in Austin, Texas.

Discussion Icon

Discuss this news

Share this article in the AGA Community, your member-only platform for sharing your thoughts and ideas with your colleagues.

Not a member? Join AGA.

By using this site, you agree to our updated Privacy Policy.